European Patent Office Receives Memorial Sloan Kettering Cancer Center and Max Planck Gesellschaft's Patent Application for HLA Class I Sequence Divergence and Cancer Therapy

Press/Media

Period12 Sep 2022

Media coverage

1

Media coverage

  • TitleEuropean Patent Office Receives Memorial Sloan Kettering Cancer Center and Max Planck Gesellschaft's Patent Application for HLA Class I Sequence Divergence and Cancer Therapy
    Media name/outletGlobal IP News. Medical Patent News
    Country/TerritoryIndia
    Date12/09/22
    PersonsDiego Chowell